DarshanTalks Podcast

406 Episodo

1. Anti-Kickback Settlement Surge

   Publicado: 20/8/2019
2. Insys & Mallinckrodt: Is Legal Really Necessary on Your Promotional Review Teams?

   Publicado: 15/8/2019
3. Alzheimer’s and Snake Oil Salesmen

   Publicado: 13/8/2019
4. Stem Cell Clinics

   Publicado: 13/8/2019
5. Responding to an FDA Inspection – Part 3 (Preparing a War Room)

   Publicado: 8/8/2019
6. Responding to an FDA Inspection – Part 4 (Preparing a War Room)

   Publicado: 8/8/2019
7. Responding to an FDA Inspection – Part 2 (FDA Findings, What the FDA Can Do)

   Publicado: 8/8/2019
8. Responding to an FDA Inspection – Part 1 (FDA Findings, What the FDA Can Do)

   Publicado: 8/8/2019
9. Diving Deeper Into Understanding Bioethics

   Publicado: 8/8/2019
10. 10 Ways to Communicate With the FDA

    Publicado: 1/8/2019
11. FDA and Vaping: Influencer Marketing Warning

    Publicado: 23/7/2019
12. Types of Ethics

    Publicado: 20/7/2019
13. ENDS Product Marketing: FDA releases guidance on marketing vaping products

    Publicado: 16/7/2019
14. 23&me and Ethical Engagement

    Publicado: 11/7/2019
15. FDA Warning Letter: Vivus

    Publicado: 11/7/2019
16. Government Shutdowns & Patient Centricity

    Publicado: 6/6/2019
17. CBD: FDA Hearing

    Publicado: 31/5/2019
18. Minimizing Participant Loss in Clinical Trials – Part 2

    Publicado: 30/5/2019
19. Minimizing Participant Loss in Clinical Trials – Part 1

    Publicado: 23/5/2019
20. Why Patients Aren’t Joining Your Clinical Trial – Part 2

    Publicado: 16/5/2019